We review here the current experimental evidence suggesting that activation of the ACE2/Ang-(1–9) pathway protects the heart and vessels (and possibly the kidney) from adverse cardiovascular remodeling in hypertension as well as in heart failure. This evidence concerns the gene ACE2 and heart failure.